Roche

Roche returns to MediLink with $570M near-term payments for ADC

Roche has got in on the B7-H3 action, agreeing to $570 million in near-term payments to partner MediLink Therapeutics for an ADC targeting the protein

James Waldron Jan 9, 2026 5:40am

Ollin eyes phase 3 after topping Vabysmo in early-stage trial

Jan 8, 2026 3:20pm

Roche commits $100M to keep its GLP-1 Structure sound

Jan 6, 2026 10:21am

Addition Tx does the math and emerges from stealth with $100M

Dec 17, 2025 7:45am

Dealmaking flurry continues with Genentech-Caris cancer collab

Dec 16, 2025 11:00am

An arrow incrementally going up stairs before pointing straight up Blue background

Roche links SERD to 30% breast cancer risk reduction in phase 3

Dec 10, 2025 8:15am